These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3821370)

  • 21. Characterization of the effects of the acute and chronic administration of phencyclidine on body temperature in the rat: lack of evidence for the involvement of opiate receptors.
    Pechnick RN; George R
    J Pharmacol Exp Ther; 1989 Mar; 248(3):900-6. PubMed ID: 2539463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyper- and hypothermia induced by non-noxious stress: effects of naloxone, diazepam and gamma-acetylenic GABA.
    Vidal C; Suaudeau C; Jacob J
    Life Sci; 1983; 33 Suppl 1():587-90. PubMed ID: 6686638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of naloxone and naltrexone on meal patterns of freely-feeding rats.
    Kirkham TC; Blundell JE
    Pharmacol Biochem Behav; 1987 Mar; 26(3):515-20. PubMed ID: 3575366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclasses of opioids based on body temperature change in rats: acute subcutaneous administration.
    Geller EB; Hawk C; Keinath SH; Tallarida RJ; Adler MW
    J Pharmacol Exp Ther; 1983 May; 225(2):391-8. PubMed ID: 6842402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reinstatement of precipitated narcotic withdrawal hypothermia in the rat.
    Ary M; Lomax P
    Life Sci; 1976 Jun; 18(11):1199-202. PubMed ID: 945438
    [No Abstract]   [Full Text] [Related]  

  • 26. Naloxone and naltrexone block the gastrointestinal effects of TRH and MK-212.
    Horita A; Carino MA; Fatherazi S; Lai H; Pae YS
    Proc West Pharmacol Soc; 1984; 27():385-6. PubMed ID: 6436825
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone.
    Porter SJ; Somogyi AA; White JM
    Addict Biol; 2002 Apr; 7(2):219-25. PubMed ID: 12006217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothermic effect of D-Ala-deltorphin II, a selective delta opioid receptor agonist.
    Broccardo M; Improta G
    Neurosci Lett; 1992 May; 139(2):209-12. PubMed ID: 1319015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the hypothermic effect of alpha-methyldopa mediated by opioid peptides?
    Sitsen JM; Nijkamp FP
    J Pharm Pharmacol; 1984 Jul; 36(7):481-3. PubMed ID: 6146699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.
    Goldberg SR; Morse WH; Goldberg DM
    J Pharmacol Exp Ther; 1981 Mar; 216(3):500-9. PubMed ID: 7205630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of opioid receptor antagonists on motor-impairing effects of benzodiazepines.
    Fidecka S; Langwiński R
    Pol J Pharmacol; 2000; 52(3):187-93. PubMed ID: 11055575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Core temperature changes following administration of naloxone and naltrexone to rats exposed to hot and cold ambient temperatures. Evidence for the physiological role of endorphins in hot and cold acclimatization.
    Thornhill JA; Cooper KE; Veale WL
    J Pharm Pharmacol; 1980 Jun; 32(6):427-30. PubMed ID: 6106678
    [No Abstract]   [Full Text] [Related]  

  • 34. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naloxone: analeptic action unrelated to opiate receptor antagonism?
    Kraynack BJ; Gintautas JG
    Anesthesiology; 1982 Apr; 56(4):251-3. PubMed ID: 6121523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet.
    Apfelbaum M; Mandenoff A
    Pharmacol Biochem Behav; 1981 Jul; 15(1):89-91. PubMed ID: 7291235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the anti-arrhythmic potency of naltrexone in the isolated ischaemic rat heart.
    Liu XL; Mok CP; Lee YS; Wong TM
    Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):40-3. PubMed ID: 3188932
    [No Abstract]   [Full Text] [Related]  

  • 38. Saccharin exposure increases the potency and aversive property of naloxone in drug-naive rats.
    Walker MJ; Leavitt B; Mucha RF
    Life Sci; 1988; 43(16):1305-11. PubMed ID: 3172982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
    Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
    Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of naltrexone on plasma corticosterone in opiate-naive rats: a central action.
    Eisenberg RM
    Life Sci; 1984 Mar; 34(12):1185-91. PubMed ID: 6538628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.